| Ident. | Authors (with country if any) | Title |
|---|
| 000202 (2012) |
Hossein Ardehali [États-Unis] ; Hani N. Sabbah [États-Unis] ; Michael A. Burke [États-Unis] ; Satyam Sarma [États-Unis] ; Peter P. Liu [Canada] ; John G. F. Cleland [Royaume-Uni] ; Aldo Maggioni [Italie] ; Gregg C. Fonarow [États-Unis] ; E. Dale Abel [États-Unis] ; Umberto Campia [États-Unis] ; Mihai Gheorghiade [États-Unis] | Targeting myocardial substrate metabolism in heart failure: potential for new therapies |
| 000378 (2011) |
Joseph B. Dubé [Canada] ; Christopher T. Johansen [Canada] ; Robert A. Hegele [Canada] | Sortilin: An unusual suspect in cholesterol metabolism |
| 000447 (2011) |
M. Luce [Canada] ; M. Levasseur [Canada] ; M. G. Scarratt [Canada] ; S. Michaud [Canada] ; S. Royer [Canada] ; R. Kiene [États-Unis] ; C. Lovejoy [Canada] ; M. Gosselin [Canada] ; M. Poulin [Canada] ; Y. Gratton [Canada] ; M. Lizotte [Canada] | Distribution and microbial metabolism of dimethylsulfoniopropionate and dimethylsulfide during the 2007 Arctic ice minimum |
| 000898 (2008) |
Jill C. Mwenifumbo [Canada] ; Nael Al Koudsi [Canada] ; Man Ki Ho [Canada] ; Qian Zhou [Canada] ; Ewa B. Hoffmann [Canada] ; Edward M. Sellers [Canada] ; Rachel F. Tyndale [Canada] | Novel and established CYP2A6 alleles impair in vivo nicotine metabolism in a population of Black African descent |
| 000A22 (2007) |
Erik S. Carlson [États-Unis] ; John D. H. Stead [Canada] ; Charles R. Neal [États-Unis] ; Anna Petryk [États-Unis] ; Michael K. Georgieff [États-Unis] | Perinatal iron deficiency results in altered developmental expression of genes mediating energy metabolism and neuronal morphogenesis in hippocampus |
| 000A55 (2007) |
Gonzalo Arboleda [Royaume-Uni, Colombie] ; Tze-Jen Huang [Royaume-Uni] ; Catherine Waters [Royaume-Uni] ; Alex Verkhratsky [Royaume-Uni] ; Paul Fernyhough [Royaume-Uni, Canada] ; Rosemary M. Gibson [Royaume-Uni] | Insulin‐like growth factor‐1‐dependent maintenance of neuronal metabolism through the phosphatidylinositol 3‐kinase–Akt pathway is inhibited by C2‐ceramide in CAD cells |
| 000A68 (2007) |
Francesca Cicchetti [Canada, États-Unis] ; Robert E. Gross [États-Unis] ; Jeff W. M. Bulte [États-Unis] ; Mary Owen [États-Unis] ; Iris Chen [États-Unis] ; Martine Saint-Pierre [Canada] ; Xukui Wang [États-Unis] ; Meixiang Yu [États-Unis] ; Anna-Liisa Brownell [États-Unis] | Dual‐modality in vivo monitoring of subventricular zone stem cell migration and metabolism |
| 000B10 (2006) |
Katarina Aleksa [Canada] ; Shinya Ito [Canada] ; Gideon Koren [Canada] | Enantioselective metabolism of ifosfamide by the kidney |
| 000C23 (2006) |
G D Dakubo ; R L Parr ; L C Costello [États-Unis] ; R B Franklin [États-Unis] ; R E Thayer | Altered metabolism and mitochondrial genome in prostate cancer |
| 000E62 (2003) |
Hongxia Li [Canada] ; Jan P. Boon [Pays-Bas] ; Wilma E. Lewis [Pays-Bas] ; Martin Van Den Berg [Pays-Bas] ; Madeleine Nyman [Finlande] ; Robert J. Letcher [Canada, Pays-Bas, Finlande] | Hepatic microsomal cytochrome P450 enzyme activity in relation to in vitro metabolism/inhibition of polychlorinated biphenyls and testosterone in Baltic grey seal (Halichoerus grypus) |
| 001403 (1999) |
Marion L. Williams [Canada, États-Unis] ; Irving W. Wainer [Canada, États-Unis] ; Leanne Embree [Canada] ; Michael Barnett [Canada] ; Camille L. Granvil [États-Unis] ; Murray P. Ducharme [Canada] | Enantioselective induction of cyclophosphamide metabolism by phenytoin |
| 001412 (1999) |
E. H. Danielsen [Danemark] ; D. F. Smith [Danemark] ; A. D. Gee [Danemark] ; T. K. Venkatachalam [Danemark] ; S. B. Hansen [Danemark] ; F. Hermansen [Danemark] ; A. Gjedde [Danemark, Canada] ; P. Cumming [Danemark, Canada] | Cerebral 6‐[18F]fluoro‐L‐DOPA (FDOPA) metabolism in pig studied by positron emission tomography |
| 001535 (1998) |
Susan Rotzinger [Canada] ; Jian Fang [Canada] ; Ronald T. Coutts [Canada] ; Glen B. Baker [Canada] | Human CYP2D6 and metabolism of m-chlorophenylpiperazine |
| 001667 (1997) |
Poh-Gek Forkert ; Raymond P. Lee | Metabolism of Ethyl Carbamate by Pulmonary Cytochrome P450 and Carboxylesterase Isozymes: Involvement of CYP2E1 and Hydrolase A |
| 001863 (1996) |
Rabeea F. Omar ; Harry V. Gelboin [États-Unis] ; Anver D. Rahimtula | Effect of cytochrome P450 induction on the metabolism and toxicity of ochratoxin A |
| 001B28 (1994) |
E. Scarr [Canada] ; D. M. Wingerchuk [Canada] ; A. V. Juorio [Canada] ; I. A. Paterson [Canada] | The effects of monoamine oxidase B inhibition on dopamine metabolism in rats with nigro-striatal lesions |
| 001B59 (1994) |
K. Shannak ; A. Rajput [Canada] ; B. Rozdilsky [Canada] ; S. Kish ; J. Gilbert [Canada] ; O. Hornykiewicz | Noradrenaline, dopamine and serotonin levels and metabolism in the human hypothalamus: observations in Parkinson's disease and normal subjects |
| 001B66 (1994) |
P Ivi Pelkonen [Finlande] ; Gordon M. Kirby [Canada] ; Christopher P. Wild [France] ; Helmut Bartsch [France] ; Matti A. Lang [France] | Metabolism of nitrosamines and aflatoxin B1 by hamster liver CYP2A enzymes |
| 002105 (1990) |
R. F. Peppard ; W. R. W. Martin [Canada] ; C. M. Clark ; G. D. Carr ; P. L. Mcgeer ; D. B. Calne | Cortical glucose metabolism in parkinson's and alzheimer's disease |
| 002291 (1988) |
Leif Hertz [Canada] ; J Rgen Drejer [Danemark] ; Arne Schousboe [Danemark] | Energy metabolism in glutamatergic neurons, GABAergic neurons and astrocytes in primary cultures |
| 002641 (1983) |
L. Lima [Venezuela, Canada] ; J. M. Díaz Borges [Venezuela] ; R. Walder [Venezuela] | Influence of Venezuelan equine encephalomyelitis virus on catecholamine metabolism in mouse CNS: Early changes in turnover rates and content |
